Peptide History intermediate
History of Peptide Clinical Development
The evolution of peptide drugs through clinical trials from insulin to modern therapeutics.
By Encyclopeptide Editorial | 1 min read
clinical development trials history
Overview
Peptide clinical development has progressed from simple hormone replacements to sophisticated targeted therapies across multiple disease areas.
Milestones
- 1922: First insulin clinical use
- 1970s: GnRH agonists in cancer trials
- 1980s: Cyclosporine transplant trials
- 1990s: Enfuvirtide HIV trials
- 2000s: Exenatide diabetes trials
- 2010s: GLP-1 obesity trials
- 2020s: Peptide drug conjugate trials
Challenges
Short half-life, injection delivery, and manufacturing complexity have historically limited peptide clinical development.
Advances
PEGylation, lipidation, and novel delivery technologies have overcome many historical limitations.
References
- Source: ENCP Peptide Database
- Category: Peptide History
Test Your Knowledge
Reinforce what you learned about History of Peptide Clinical Development with interactive quizzes on Wikipept.
Take a Quiz on Wikipept